Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0001415889-24-017040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-14 | 2024-06-12 | GPCR | Stevens Raymond C | CEO, Dir | M - OptEx | $0.42 | +150.0K | 743.3K | +25% | +$63.0K |
| DM | 2024-06-14 | 2024-06-12 | GPCR | Stevens Raymond C | CEO, Dir | M - OptEx | $0.00 | -150.0K | 1 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-12 | M | A | 50,001 | $0.48 | 793,346 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-06-12 | M | A | 99,999 | $0.39 | 743,345 | D | — | — | |
| 3 | Derivative | Share Option (right to buy) | 2024-06-12 | M | D | 50,001 | $0.00 | 488,766 | D | $0.48 · — to 2031-01-21 | 50,001 Ordinary Shares | (F2) The shares vest in a series of 48 successive equal monthly installments beginning one month after January 22, 2021. |
| 4 | Derivative | Share Option (right to buy) | 2024-06-12 | M | D | 99,999 | $0.00 | 1 | D | $0.39 · 2019-05-16 to 2030-01-21 | 99,999 Ordinary Shares |